Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

403

HTML

2420

Figures (1-2)

117

Tables (1-4)

118

Sum=3058

Feb 15, 2002 (publication date) through Apr 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Feb 15, 2002; 8(1): 69-73
Published online Feb 15, 2002. doi: 10.3748/wjg.v8.i1.69

Figure 1 Concentration-time curve of ¹⁸⁸Re -HAb18 F(ab’)₂ in nude mice

Figure 2 Binding assay for determination of immunoreactive fraction of ¹⁸⁸Re-labeled HAb18 F(ab’)₂.

Citation: Lou C, Chen ZN, Bian HJ, Li J, Zhou SB. Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb ¹⁸⁸Re-HAb18. World J Gastroenterol 2002; 8(1): 69-73
URL: https://www.wjgnet.com/1007-9327/full/v8/i1/69.htm
DOI: https://dx.doi.org/10.3748/wjg.v8.i1.69